Co-Diagnostics, Inc. (CODX)
About Co-Diagnostics, Inc.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $622.5K
- Net income
- -$46.9M
- Total assets
- $24.7M
- Market cap
- $7.7M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $7.7M
- Shares outstanding
- 16.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 12, 2017
Co-Diagnostics, Inc. (CODX) Stock Price
- Reported a net loss of $46.9M in FY2025.
- Trading 99% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Co-Diagnostics, Inc..
Write a review
News about Co-Diagnostics, Inc.
News & sentiment via Polygon.io
Co-Diagnostics, Inc.: frequently asked questions
Is Co-Diagnostics, Inc. an American company?
Co-Diagnostics, Inc. is a US-based company headquartered in Salt Lake City, Utah, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Co-Diagnostics, Inc. headquartered?
Co-Diagnostics, Inc. is headquartered in Salt Lake City, Utah, United States.
Is Co-Diagnostics, Inc. publicly traded?
Yes — Co-Diagnostics, Inc. is a publicly traded company. Its stock trades under the ticker symbol CODX on the NASDAQ.
What does Co-Diagnostics, Inc. do?
Co-Diagnostics, Inc. is an American Medical Devices company in the Health & Beauty sector.
